Applications Published 2 May 2001
Published: 20-Jan-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Sustained release pharmaceutical preparation
Cascade Development 1094790*Thixotropic formulations for filling capsules
Pieere Fabre Medicament 1094791*Materials and methods relating ro encapsulation
Ecole Polytechnique Federale de Lausanne 1094792*Compsn containing glycerol trinitrate, method for producing said compsn and use of the same
LTS Lohmann Therapie-Systeme 1094793*Dry-coping method of producing flat, individually dosed preparations of active agents
LTS Lohmann Therapie-Systeme 1094794*Topical plaster with non-steroidal antirheumatic agents with an acid group
LTS Lohmann Therapie-Systeme 1094766*Trandermal plaster containing at least one active ingredient which influences blood serum lipid levels
LTS Lohmann Therapie-Systeme 1094767*Inhibitors of type 5 and type 3 17betahydroxysteroid dehydrogenase and methods for their use
Endrorecherche 1094798*Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
Pentech Pharmaceuticals 1094799*Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefore
The Salk Institute for Biological Studies 1094800*Poly(diallylamine)-based bile acid sequestrants
Geltex Pharmaceuticals 1094801*Pharmaceutical compsn for injection based on paracetamol
Aziende Chimiche Riunite Angelini Francesco 1094802*Use of GABA analogs for treating insomnia
Warner-Lambert 1094803*The treatment of renal colic with GABA analogs
Warner-Lambert 1094804*Subtituted oxygen alicyclic compounds, including methods for synthesis thereof
Millennium Pharmaceuticals 1094805*Vasculoprotector
Karo Bio 1094806*Vitamin E and esters thereof for use in the topical treatment of mucosal pathologies Panin, Giorgio 1094807*Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
Pfizer 1094808*Use of histamine H2 mimicking substances for the treatment of multiple sclerosis
Delack, Elaine 1094809*Use of phenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric G protein membrane fixation
Societe de Conseils de Recherches et d'Applications Scientifiques 1094810*New use
AstraZeneca 1094811*Angiogenesis inhibitors
The Scripps Research Institute 1094812*Use of piperidine for treating skin pigmentation disorders.
BTG International 1094813*Methods and compsns for increasing penetration of HIV protease inhibitors
Glaxo Group 1094814*Farnesyl protein transferase inhibitors for treating arthropathies
Janssen Pharmaceutica 1094815*Biphenyl sulphonamides as dual angiotensin endothelin recpetor antagonists
Bristol-Myers Squibb 1094816*Compsns comprising GABA analogs and caffeine
Warner-Lambert 1094817*Use of tricyclic antidepressants for local analgesia
Dalhousie University 1094818*Injectable sodium acylsalicylate compsn and method
Galat, Alexander 1094819*Use of bisphosphonates in the treatment of vascular restenosis
Yissum Research Development Organisation of the Hebrew University of Jerusalem 1094820*Preparation and use of sulphur-containing phosphonoformate derivatives and analogs
The University of Southern California 1094821*Water-miscible macrolide solutions
Merial 1094822*Use of alpha-D-glucans for promoting cutaneous wound and ulcer healing
Idexx Laboratories 1094823*Prophylactic and therapeutic nutritional supplement for the creation/maintenance of health-protective intestinal microflora and enhancement of the immune system
Crum, Albert; Zivkovic, D Dorothy 1094824*Pharmaceutical grade St John's Wort
Pharmaprint; University of Southern California 1094825*Novel therapeutic agents that modulate alpha-1A adrenergic receptors
Advanced Medicine 1094826*Prion protein and uses thereof
VI Technologies 1094827*Use of neglected target tissue antigens in modulation of immune responses
The Regents of the University of California 1094828*Methods for accelerating bone and cartilage growth and repair
University of Southern California 1094829*Use of compsn comprising at least one substance within the group GNRH-analogs for treatment of obsessive-compulsive disorder (OCD)
Laekartjaenster I Vaestsverige 1094830*Compsns and methods for in vitro fertilisation
The United States Government as represented by the Department of Health and Human Service, Office of Technology Transfer 1094831*Therapeutic use of uncoupling protein-HHFCW60
SmithKline Beecham 1094832*
